Palladium catalyzed amination of 2-chloro-1,3-azole derivatives: Mild entry to potent H1- antihistaminic norastemizole

Tetrahedron Letters

Volumn 38, Issue 32, 1997, Pages 5607-5610

  Hong, Yaping ^a   Tanoury, Gerald J ^a   Wilkinson, H Scott ^a   Bakale, Roger P ^a   Wald, Stephen A ^a   Senanayake, Chris H ^a  

^a SUNOVION PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZIMIDAZOLE DERIVATIVE; HISTAMINE H1 RECEPTOR ANTAGONIST; NORASTEMIZOLE;

AMINATION; ARTICLE; CATALYSIS; DRUG SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; REACTION ANALYSIS;

EID: 0030763062     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4039(97)01273-2     Document Type: Article

References (26)

1. (a) Janssens, F.; Torremans, J.; Janssen, M.; Stokbroekx, R. A.; Luyckx, M.; Janssen, P. A. J. Med . Chem. 1985, 28, 1925.
2. (b) Janssens, F.; Torremans, J.; Janssen, M.; Stokbroekx, R. A.; Luyckx, M.; Janssen, P. A. J. Med. Chem. 1985, 28, 1943.
3. (c ) Jung, F.; Boucherot, D.; Delvare, C.; Olivier, A. J. Antibiot, 1993, 46, 993.
4. (d) Keler, S. US patent 2578,757.
5. (e) Fujimoto, K. J. Antibiot. 1987, 40, 370.
6. Cooper, D. G.; Young, R. C.; Durant, G. J.; Gamellin, C. R. Histamine Receptors, in " Comprehensive Medicinal Chemistry" , Hansch, C., Sammes, P. G. and Taylor, J. B. Eds.; Pergamon Press: Oxford, 1990, 3, 323.
7. (a) McCullough, J. R; Butler, H. T.; Fang, K. Q.; Handley, D. A. "Receptor binding properties of astemizole and its metabolite norastemizole" American College of Allergy, Asthma and Immunology Boston, November, 1996, 8.
8. (b) McCullough, J. R.; Jolly, S. R.; Fang, K. Q.; Weishaar, R. E. "The effects of astemizole and norastemizole on cardiovascular responses in conscious dogs" American College of Allergy, Asthma and Immunology Boston, November, 1996, 8
9. (c) Handley, D. A.; McCullough, J, Fang, K. Q.; Wright S. E.; Smith R. E. "Comparative antihistaminic effects of astemizole and a metabolite , norastemizole" American College of Allergy, Asthma and Immunology Boston, November, 1996, 8.
10. (a) Kym, O.; Ratner, L, Ber, 1912, 45, 3238.
11. (b) Efros, L. S.; Porai, B. A.; Farbenshtein, Zhur. Obshch. Khim., 1953, 23, 1691.
12. (c) Brown, D. J. J. Chem. Soc., 1958, 1974.
13. (d) Grimmett, R. M. Adv. Heterocycl. Chem., 1970, 12, 103.
14. (e) Grimmett, R. M. Adv. Heterocycl. Chem., 1980, 27, 241.
15. (f) Subrayan, P. R.; Kampf, W. J.; Rasmussen, P. G. J. Org. Chem. 1994, 59, 4341.
16. Parrodi, C. A.; Cortes, L. Q.; Ramfrez, J. S. Syn. Com., 1996, 3323.
17. (a) Wolfe, J. P.; Wagaw, S.; Buchwald, L. S. J Am. Chem. Soc. 1996, 118, 7215.
18. (b) Wagaw, S.; Buchwald, L. S. J. Org. Chem. 1996, 61, 7241.
19. (c) Wolfe, J. P.; Buchwald, L. S. J. Org. Chem. 1996, 61, 1135.
20. (a) Paul, F.; Patt, J.; Hartwig, J. F. J. Am. Chem. Soc. 1994, 116, 5969.
21. (b) Driver, M. S.; Hartwig, J. F. J. Am. Chem. Soc. 1995, 117, 4708.
22. (c) Driver, M. S.; Hartwig, J. F. J. Am. Chem. Soc. 1996, 118, 7217.
23. Beller, M.; Riermeier, T. H.; Reisinger, C.; Herrmann, W. A. Tetrahedron Lett. 1997, 2073.
24. 3 (0.25 mol%), BINAP (0.75%)) in the presence of 4.2 equivalence of NaOtBu very low reactivity of both amines was observed ( 17:1 ratio of 1:6 with a 85% conversion after 20h).
25. Unprotected piperazine mono aminations: Zhao, S. H.; Miller, A, K.; Berger, J.; Flippin, L. A. Tetrahedron Lett. 1996, 4463
26. 19F coupling), 155.6, 153.3, 142.2, 134.5, 131.4, 128.3, 121.8, 120.0, 116.6, 116.3, 116.1, 107.5, 61.5, 50.1, 45.0, 42.8, 32.6, 14.8.